Literature DB >> 30978764

[Slow Transit Constipation].

Marco Sailer1.   

Abstract

Slow transit constipation is a rare condition that is almost exclusively encountered in middle-aged women. The pathophysiology and aetiology are poorly understood, but a multi-factorial pathogenesis seems likely. In the course of the differential diagnosis, mechanical, drug-induced, degenerative, metabolic, endocrinological, neurological and psychiatric causes of constipation must be excluded by an interdisciplinary approach. Gastrointestinal physiological investigations are mandatory, including measurement of colonic transit. Furthermore, pangastrointestinal transit delay, pelvic floor dysfunction and irritable bowel syndrome should be excluded. The initial mode of treatment is strictly conservative. In cases of progression or persistence of symptoms, surgical therapy should be discussed. Subtotal colectomy with ileorectal anastomosis can be regarded as the standard operation for slow transit constipation. Postoperative complications include small bowel obstruction, incontinence and persistence or recurrence of constipation and/or abdominal pain. Using strict criteria for patient selection, overall success rates are reported in excess of 80%. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2019        PMID: 30978764     DOI: 10.1055/a-0860-5960

Source DB:  PubMed          Journal:  Zentralbl Chir        ISSN: 0044-409X            Impact factor:   0.942


  2 in total

1.  Zhizhu Decoction Alleviates Intestinal Barrier Damage via Regulating SIRT1/FoxO1 Signaling Pathway in Slow Transit Constipation Model Mice.

Authors:  Yong Wen; Yu Zhan; Shi-Yu Tang; Fang Liu; Qiu-Xiao Wang; Peng-Fei Kong; Xue-Gui Tang
Journal:  Chin J Integr Med       Date:  2022-08-31       Impact factor: 2.626

Review 2.  [The paraplegic patient-Characteristics of diagnostics and treatment in visceral surgery].

Authors:  Julia Seifert; Ralf Böthig; Stefan Wolter; Jakob R Izbicki; Roland Thietje; Michael Tachezy
Journal:  Chirurg       Date:  2021-02-25       Impact factor: 0.955

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.